The development of tissue engineering procedure for osteogensesis -investigation using plate rich plasma and mesenchymal stem cell-
成骨组织工程程序的开发 - 使用富含平板的血浆和间充质干细胞进行研究 -
基本信息
- 批准号:17390416
- 负责人:
- 金额:$ 9.63万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Distraction osteogenesis (DO) has become a widely used and accepted procedure in patients with limb length discrepancy or large bone defect, but the treatment period is long which results in higher rates of complications. Good bone formation during DO is essential to minimize the treatment time and reduce associated complications. We considered that DO is good model for investigating the biology of osteogensis. Tissue engineering strategy, which consists of three essential components (application of osteogenic cells, osteoinductive factors, and a scaffold), has emerged as a possible alternative to accelerate bone regeneration at the distracted gap.Bone marrow-derived mesenchymal stem cells(BMC)can be directed towards the osteogenic lineage if cultured in the presence of dexamethasone. Osteogenic potential can be maintained even in BMSCs that have been passaged several times in the presence of hrBMP-2. Platelet rich plasma(PRP)contains several osteoinductive growth factors including pla … More telet-derived growth factor, insulin-like growth factor, and transforming growth factors. PRP increased the number of BMC, but did not promote osteogenic potential in cultured BMC cells. Several investigators have reported that the injection of cells into the distracted callus enhanced bone formation However, the injected cells may move to the surrounding tissue, leading to a reduced concentration in the target area. Therefore, the scaffold is important factor. We concluded PRP can be a suitable carrier for cell transplantation because it coagulates immediately by an addition of thrombin and calcium from our studies. The weight bearing and movement may be another factor to develop osteogenesis in DO. We revealed that the weight bearing with distracted leg stimulated bone formation compared to non-weight bearing condition.For the clinical application of BMC based therapy, autologous PRP was used to prevent disease transmission and immunoreactions. The transplantation of BMC and PRP during DO may be regarded as promising procedure. Less
牵引成骨(DO)已成为肢体长度不等或大骨缺损患者广泛使用和接受的手术,但治疗周期长,导致并发症发生率较高,DO期间良好的骨形成对于最大限度地缩短治疗时间至关重要。我们认为 DO 是研究成骨生物学的良好模型,该策略由三个基本组成部分(成骨细胞、骨诱导因子和支架的应用)组成,已成为一种可能的替代方案。加速骨再生如果在地塞米松存在下培养,骨髓来源的间充质干细胞 (BMC) 可以定向向成骨谱系,即使在 hrBMP-2 存在下传代数次的 BMSC 中也可以保持成骨潜力。富血小板血浆(PRP)含有多种骨诱导生长因子,包括血小板源性生长因子、胰岛素样生长因子和增加 PRP 数量的转化生长因子。一些研究人员报告说,将细胞注射到分散的愈伤组织中可以增强骨形成,但注射的细胞可能会移动到周围组织,导致目标区域的浓度降低。因此,我们得出结论,PRP 可以成为细胞移植的合适载体,因为根据我们的研究,它通过添加凝血酶和钙而立即凝固,负重和运动可能是 DO 中成骨的另一个因素。我们透露与非负重条件相比,分心腿的负重刺激了骨形成。对于基于BMC的治疗的临床应用,自体PRP用于预防疾病传播和免疫反应,DO期间BMC和PRP的移植可能被认为是有前途的。程序.更少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages
- DOI:10.1080/17453670710013816
- 发表时间:2007-01-01
- 期刊:
- 影响因子:3.7
- 作者:Ishikawa, Hisato;Kitoh, Hiroshi;Ishiguro, Naoki
- 通讯作者:Ishiguro, Naoki
Structural allograft incorporation enhanced by autologous bone . marrow cells or bone marrow derived osteoblast-like cells
自体骨增强同种异体结构的融合。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:T. Masui;S. Sakano;Y. Hasegawa;J. Yamaguchi;T. Kanoh;N. Ishiguro
- 通讯作者:N. Ishiguro
Effects of tensile and compressive strains on response of a chondrocytic cell line embedded in type I collagen gel
- DOI:10.1016/j.jbiotec.2007.07.955
- 发表时间:2008-01-20
- 期刊:
- 影响因子:4.1
- 作者:Hirano, Yuji;Ishiguro, Naoki;Naruse, Keiji
- 通讯作者:Naruse, Keiji
Involvement of reactive oxygen species in cyclic stretchinduced NF- K B activation in human fibroblast cells
活性氧参与循环拉伸诱导的人成纤维细胞 NF-κB 激活
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:H. Amma;K. Naruse;N. Ishiguro;M. Sokabe
- 通讯作者:M. Sokabe
Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity
- DOI:10.1016/j.yexcr.2005.03.026
- 发表时间:2005-07-01
- 期刊:
- 影响因子:3.7
- 作者:Nishida, Y;Knudson, W;Ishiguro, N
- 通讯作者:Ishiguro, N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ISHIGURO Naoki其他文献
ISHIGURO Naoki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ISHIGURO Naoki', 18)}}的其他基金
Development of a new therapeutic drug for osteoarthritis that has a cartilage-protecting effect by inhibiting Wnt/ADAM10
开发通过抑制Wnt/ADAM10具有软骨保护作用的骨关节炎新治疗药物
- 批准号:
19H03779 - 财政年份:2019
- 资助金额:
$ 9.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
TRPV4, a Ca ion channel plays pivotal role in chondrogenic mechanotransduction in ATDC5
TRPV4,一种 Ca 离子通道,在 ATDC5 的软骨形成机械转导中发挥关键作用
- 批准号:
24659671 - 财政年份:2012
- 资助金额:
$ 9.63万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The research of the drugs that can promote SOX9m RNA expression in chondrocyte
促进软骨细胞SOX9m RNA表达的药物研究
- 批准号:
22659269 - 财政年份:2010
- 资助金额:
$ 9.63万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The Research of the bioreactor that can promote the cell differentiation from bone marrow stem cells to osteogenic cells
促进骨髓干细胞向成骨细胞分化的生物反应器的研究
- 批准号:
21390419 - 财政年份:2009
- 资助金额:
$ 9.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The application of osteoblast-like cells and platelet rich plasma gels transplantation for accelerating the bone regeneration in the distraction osteogenesis.
成骨细胞样细胞和富血小板血浆凝胶移植在牵引成骨中加速骨再生的应用。
- 批准号:
14370461 - 财政年份:2002
- 资助金额:
$ 9.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The effects of degenerative products from matrix on syanovial cells and chondrocytes metabolism
基质变性产物对滑膜细胞和软骨细胞代谢的影响
- 批准号:
09470312 - 财政年份:1997
- 资助金额:
$ 9.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Biologic reaction in interface tissue of aseptic loosening THA.
无菌松动THA界面组织的生物反应。
- 批准号:
07457330 - 财政年份:1995
- 资助金额:
$ 9.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
Let-7靶向抑制BMP2在骨髓间充质干细胞源性外泌体抑制血管钙化中的作用及机制研究
- 批准号:81900441
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
BMP2/Gm26778/β-catenin信号通路参与调控老龄化BM-MSCs成骨分化的机制研究
- 批准号:81800786
- 批准年份:2018
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
加载rhBMP2纳米短肽水凝胶RADA16-I促进hUC-MSCs牙向分化再生牙髓的实验研究
- 批准号:81660182
- 批准年份:2016
- 资助金额:36.0 万元
- 项目类别:地区科学基金项目
Smad7在Sox9增强BMP2诱导软骨分化中的作用和机制研究
- 批准号:81572142
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
Sox9对BMP2诱导间充质干细胞成软骨分化的影响及机制研究
- 批准号:81371972
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目